Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells

[1]  H. Weiner,et al.  Oral tolerance , 2011, Immunological reviews.

[2]  H. Weiner,et al.  Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells , 2009, Lupus.

[3]  H. Weiner,et al.  Nasal Anti-CD3 Antibody Ameliorates Lupus by Inducing an IL-10-Secreting CD4+CD25−LAP+ Regulatory T Cell and Is Associated with Down-Regulation of IL-17+CD4+ICOS+CXCR5+ Follicular Helper T Cells1 , 2008, The Journal of Immunology.

[4]  H. Weiner,et al.  Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis , 2008, Journal of Neuroimmunology.

[5]  R. Steinman,et al.  Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity , 2007, Immunological reviews.

[6]  H. Weiner,et al.  A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells , 2007, Nature Immunology.

[7]  R. Steinman,et al.  Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells , 2007, The Journal of experimental medicine.

[8]  V. Cerundolo,et al.  A closer look at CD1d molecules: new horizons in studying NKT cells. , 2007, Trends in immunology.

[9]  J. Bluestone,et al.  CD3-specific antibodies: a portal to the treatment of autoimmunity , 2007, Nature Reviews Immunology.

[10]  H. Weiner,et al.  Inhibition of Autoimmune Diabetes by Oral Administration of Anti-CD3 Monoclonal Antibody , 2007, Diabetes.

[11]  O. Pappo,et al.  Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. , 2007, International immunology.

[12]  M. Battaglia,et al.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.

[13]  Irun R Cohen,et al.  Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. , 2007, The Journal of clinical investigation.

[14]  U. Yrlid,et al.  Regulation of intestinal immunity: Effects of the oral adjuvant Escherichia coli heat‐labile enterotoxin on migrating dendritic cells , 2007, European journal of immunology.

[15]  D. Friedman,et al.  β-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders , 2006, Gut.

[16]  Y. Ilan,et al.  Glycolipids as immune modulatory tools. , 2006, Mini reviews in medicinal chemistry.

[17]  M. Gomori,et al.  Glucocerebroside Ameliorates the Metabolic Syndrome in OB/OB Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[18]  H. Weiner,et al.  IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production , 2006, The Journal of Immunology.

[19]  H. Weiner,et al.  Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells , 2006, Nature Medicine.

[20]  E. Elinav,et al.  Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[21]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[22]  F. León,et al.  Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease , 2005, Immunological reviews.

[23]  Eytan Domany,et al.  Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Cohen,et al.  The natural autoantibody repertoire and autoimmune disease. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Eytan Domany,et al.  Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: a bio-informatic approach to immune complexity. , 2003, Journal of autoimmunity.

[26]  Jang-June Park,et al.  Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-d-glucosylceramide synthase deficiency , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Killestein.  Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.

[28]  I. Cohen,et al.  Autoantibody patterns in diabetes-prone NOD mice and in standard C57BL/6 mice. , 2001, Journal of autoimmunity.

[29]  H. Weiner.  The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells , 2001, Nature Immunology.

[30]  J. Phillips,et al.  Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. , 1999, Transplantation.

[31]  J. Stockman.  Insulin Needs After CD3-Antibody Therapy in New-Onset Type 1 Diabetes , 2007 .

[32]  H. Oberg,et al.  Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. , 2006, Critical reviews in immunology.

[33]  Dov Stekel,et al.  Microarray Bioinformatics: Appendix: MIAME Glossary , 2003 .

[34]  Applied Math.,et al.  Adaptive Methods for Classification of Biological Microarray Data from Multiple Experiments , 2003 .

[35]  A. Coutinho,et al.  Natural autoantibodies. , 1995, Current opinion in immunology.